
Ταυτότητα
Tofacitinib Impurity
Δεν αναφέρεται · C16H22N6O
01Ταυτότητα
| Lazychem ID | LC-38611 |
|---|---|
| CAS RN | Δεν αναφέρεται |
| PubChem CID | 70993296 |
| Molecular formula | C16H22N6O |
| Molecular weight | 314.39 g/mol |
| IUPAC name | 3-[3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile |
| InChIKey | PEURVXMHTIUQCG-UHFFFAOYSA-N |
02Δομή και στερεοχημεία

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon. These statements are calculated from the published structure string.
| Defined stereocentres | 0 |
|---|---|
| Ring count | 3 |
| Secondary amines | 1 |
| Tertiary amines | 1 |
| SMILES | CC1CCN(CC1N(C)C2=NC=NC3=C2CCN3)C(=O)CC#N |
|---|---|
| InChI | Δεν αναφέρεται |
03Stereochemistry
The published structure contains 0 defined and 2 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.
Published same-connectivity configurations
2 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.


Dihydro Tofacitinib Impurity/ 5,6-Dihydro Tofacitinib
CAS 1640972-35-5
PEURVXMHTIUQCG-YPMHNXCESA-N
2 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
04Κατάσταση στην Ινδία
Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.
05Ονόματα και σχέσεις
API και μητρικό φάρμακο
Δεν αναφέρεται
Ονόματα και σχέσεις
06Πηγές
- S01PubChem CID 70993296
Structure and machine-readable chemical identifiers.
